维普中文期刊产品整合服务
17篇 您的检索式:作者名="DEEKEN R"
    题名 作者 年代 出处 被引量
1Physicomeehanical evaluation of polypropylene, polyester, and polytetrafluoroethylene meshes for inguinal hernia repair显示文摘DEEKEN C R ABDO M S FRISELLA M M 2011Journal of the American College of Surgeons2011,212,1:1
2AKT3, a phloem-localized K^+ channel, is blocked protons显示文摘Marten I Hoth S Deeken R 1999Proc Natl Acad Sci1999,96,13:1
3An Integrated View of Gene Expression and Solute Profiles of Arabidopsis Tumors:A Genome-Wide Approach显示文摘Deeken R Engelmann JC Efetova M 2006Plant Cell2006,18,12:1
4A review of the composition, characteristics, and effectiveness of barrier mesh prostheses utilized for laparoscopic ventral hernia repair显示文摘DEEKEN C R FAUCHER K M MATTHEWS B D 2012Surgical Endoscopy2012,26,2:1
5Improvement of thermal and mechanical properties of a phenolic resin nanocomposite by in situ formation of silsesquioxanes from a molecular precursor显示文摘Schutz M R Sattler K Deeken S 2010Journal of Applied Polymer Science2010,117,4:1
6Identification of a new glucosinolate-rich cell type in Arabidopsis flower stalk 显示文摘Koroleva O A Davies A Deeken R 2000Plato Physiol2000,124,2:1
7Developmentaland light-dependent regulation of a phloem-localisedK+channel of Arabidopsis thaliana显示文摘Deeken R Sanders C Ache P 2000Plant J2000,23,:1
8VFK1,a Vicia fabaK+channel involved in phloem unloading显示文摘Ache P Becker D Deeken R 2001Plant J2001,27,:1
9Identification of a new glucosinolate-rich cell type in Arabidopsis flower stalk显示文摘KOROLEVA O A DAVIES A DEEKEN R 2000Plant Physiol2000,124,2:1
10Irinotecan and uridine diphos- phate glucurono- syltransferase 1A1 pharmacogenetics: to test or not to test, that is the question显示文摘Deeken J F Slack R Marshall J L 2008Cancer2008,113,7:1
11Identification of a new glucosinolate-rich cell type in Arabidopsis flower stalk显示文摘Koroleva O A Davies A Deeken R Thorpe M R Tomos A D Hedrich R 2000Plant Physiol2000,124,:1
12Isolation of AtSUC2 promoter-GFP-marked companion cells for patch-clamp studier and expression profiling显示文摘IVASHIKINA N DEEKEN R ACHE P 2003The Plant Journal2003,36,3:1
13Irinotecan and uridine diphosphate glucronosy hransferase 1 A1 pharm acogeneties:to test or not to test, that is the question显示文摘Deeken JF Slack R Marshall JL 2008Cancer2008,113,7:1
14Irinotecan and uridine diphosphate glucuronosyltransferase IA1 pharmacogenetics: to test or not to test, that is the question显示文摘DEEKEN J F SLACK R MARSHALL J L 2008Cancer2008,113,7:1
15A phase I study of liposomal- encapsulated docetaxel (LE-DT) in patients with advanced solid tumor malignancies 显示文摘Deeken JF Slack R Weiss GJ~ 2013Cancer Chemother Pharmacol2013,71,3:1
16Loss of the AKT2/3 potassium channel affects sugar loading into the phloem of Arabidopsis 显示文摘Deeken R Geiger D Fromm J 2002Planta2002,216,:1
17Reinforced tissue matrix to strengthen the abdominal wall following reversal of temporary ostomies or to treat incisional hernias显示文摘BACKGROUND Abdominal wall deficiencies or weakness are a common complication of tem-porary ostomies,and incisional hernias frequently develop after colostomy or ileostomy takedown.The use of synthetic meshes to reinforce the abdominal wall has reduced hernia occurrence.Biologic meshes have also been used to enhance healing,particularly in contaminated conditions.Reinforced tissue matrices(R-TMs),which include a biologic scaffold of native extracellular matrix and a syn-thetic component for added strength/durability,are designed to take advantage of aspects of both synthetic and biologic materials.To date,RTMs have not been reported to reinforce the abdominal wall following stoma reversal.METHODS Twenty-eight patients were selected with a parastomal and/or incisional hernia who had received a temporary ileostomy or colostomy for fecal diversion after rectal cancer treatment or trauma.Following hernia repair and proximal stoma closure,RTM(OviTex®1S permanent or OviTex®LPR)was placed to reinforce the abdominal wall using a laparoscopic,robotic,or open surgical approach.Post-operative follow-up was performed at 1 month and 1 year.Hernia recurrence was determined by physical examination and,when necessary,via computed tomo-graphy scan.Secondary endpoints included length of hospital stay,time to return to work,and hospital readmissions.Evaluated complications of the wound/repair site included presence of surgical site infection,seroma,hematoma,wound dehiscence,or fistula formation.RESULTS The observational study cohort included 16 male and 12 female patients with average age of 58.5 years±16.3 years and average body mass index of 26.2 kg/m^(2)±4.1 kg/m^(2).Patients presented with a parastomal hernia(75.0%),in-cisional hernia(14.3%),or combined parastomal/incisional hernia(10.7%).Using a laparoscopic(53.6%),robotic(35.7%),or open(10.7%)technique,RTMs(OviTex®LPR:82.1%,OviTex®1S:17.9%)were placed using sublay(82.1%)or intraperitoneal onlay(IPOM;17.9%)mesh positioning.At 1-month and 1-year follow-ups,there were no hernia recurrences(0%).Average hospital stays were 2.1 d±1.2 d and return to work occurred at 8.3 post-operative days±3.0 post-operative days.Three patients(10.7%)were readmitted before the 1-month follow up due to mesh infection and/or gastrointestinal issues.Fistula and mesh infection were observed in two patients each(7.1%),leading to partial mesh removal in one patient(3.6%).There were no complications between 1 month and 1 year(0%).CONCLUSION RTMs were used successfully to treat parastomal and incisional hernias at ileostomy reversal,with no hernia recurrences and favorable outcomes after 1-month and 1-year.Spencer P Lake Corey R Deeken Amit K Agarwal 2024World Journal of Gastrointestinal Surgery2024,16,3:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费